Gwenn Hansen Nurix Therapeutics, Inc. (NRIX) insider trading activity
Gwenn Hansen is Chief Scientific Officer of Nurix Therapeutics, Inc.. Currently has a direct ownership of 69,023 shares of NRIX, which is worth approximately $691,610. The most recent transaction as insider was on Apr 05, 2021, when has been sold 400 shares (Common Stock) at a price of $35.0 per share, resulting in proceeds of $14,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
69K
12.2%
3M change
52.87%
12M change
Total Value Held
$691,610
Gwenn Hansen Transaction History
GH
Gwenn Hansen
Chief Scientific Officer
San Francisco, CA